| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $120.28M | $101.55M | $76.19M | $34.65M | $8.63M |
| R&D | – | – | – | – | – |
| SG&A | – | – | – | – | – |
| Operating Income | -$118.21M | -$83.83M | -$76.19M | -$34.65M | – |
| Interest Expense | $76.36M | $61.52M | $52.31M | $20.29M | $4.46M |
| Tax Expense | $1.66M | $717.00K | – | – | – |
| Net Income | $93.71M | $131.94M | $77.08M | $45.77M | $22.29M |
| EPS (basic) | 1.6700 | 2.0300 | 2.1600 | 1.6800 | 0.9400 |
| EPS (diluted) | 1.6700 | 2.0300 | 2.1600 | 1.6800 | 0.9400 |
| Shares (diluted) | $70.26M | $63.76M | $39.25M | $27.18M | $10.72M |